Skip to main content
Watch Insiders

Corporate insider profile

Cameron Turtle Insider Trades

Latest reported as Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$7,564,560.00
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

SYRELatest reported

Spyre Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$92.01$1,380,105
Sep 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$87.29$1,309,410
Aug 3, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$95.51$1,432,706
Jul 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$87.69$1,315,347
Jun 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$70.43$1,056,486
May 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$71.37$1,070,507